At what pace is the enzymes market growing, and what is its estimated value?
The enzymes market size has grown rapidly in recent years. It will grow from $13.38 billion in 2024 to $15.33 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to globalization and market expansion, research and development investments, consumer awareness and demand, bioprocessing technology improvements, waste reduction and recycling.
The enzymes market size is expected to see rapid growth in the next few years. It will grow to $25.88 billion in 2029 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to market demand dynamics, focus on sustainable practices, health and nutrition trends, biofuel and renewable energy, emerging applications. Major trends in the forecast period include biotechnology advancements, sustainability demands, food and beverage industry demand, industrial applications expansion, consumer preference for natural products.
Get Your Free Sample of The Global Enzymes Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3425&type=smp
What are the key drivers behind the rapid expansion of the enzymes market?
The rise in prevalence of digestive disorders is expected to propel the growth of the enzyme market going forward. Digestive disorders are a group of health conditions that affect the digestive system. Some common digestive disorders include gastroesophageal reflux disease (GERD), cancer, irritable bowel syndrome (IBS), lactose intolerance, hiatal hernia, and gallstones. Digestive enzymes help break down food into smaller molecules that can be absorbed by the body. For instance, in October 2022, according to the National Center for Biotechnology Information (NCBI), a US-based resource for the scientific research community, the prevalence of irritable bowel syndrome (IBS) ranges between 10% and 15% in the United States and nearly 12% of patients seek medical care in primary care practices for IBS-related complaints. Thus, the rise in prevalence of digestive disorders is driving the growth of the enzyme market.
What is the segmentation for the enzymes market?
The enzymes market covered in this report is segmented –
1) By Product Type: Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products
2) By Application: Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications
3) By End User: Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories
Subsegments:
1) By Asparaginase: L-asparaginase, Erwinia Asparaginase, Pegylated Asparaginase
2) By Lipase: Gastric Lipase, Pancreatic Lipase, Fungal Lipase, Bacterial Lipase
3) By Protease: Serine Proteases, Cysteine Proteases, Aspartic Proteases, Metalloproteases
4) By Nattokinase: Nattokinase Powder, Nattokinase Capsules
5) By Chitinase: Plant Chitinase, Microbial Chitinase
6) By Serratiopeptidase: Serratiopeptidase Tablets, Serratiopeptidase Capsules
7) By Collagenase: Type I Collagenase, Type II Collagenase, Type III Collagenase
8) By Ligase: DNA Ligase, RNA Ligase
9) By Other Products: Amylase, Cellulase, Beta-Glucanase, Other Specialty Enzymes
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report
Who are the most influential companies in the enzymes market?
Major companies operating in the enzymes market include Novozymes A/S, DuPont Industrial Biosciences, BASF SE, Koninklijke DSM N.V., Chr. Hansen Holding A/S, Roche Holding AG, Advanced Enzyme Technologies Ltd., AB Enzymes GmbH, Codexis Inc., Dyadic International Inc., Amano Enzyme Inc., Adisseo France SAS, Biocatalysts Ltd., Amano Enzyme Inc., Enzyme Development Corporation, Creative Enzymes, Hayashibara Co. Ltd., Thermo Fisher Scientific Inc., Associated British Foods Plc, Lonza Group AG, Novus International Inc., Epygen Biotech, DSM Nutritional Products AG, Soufflet Biotechnologies SAS, Beijing Leili Marine Bioindustry Inc., Jiangsu Boli Bioproducts Co. Ltd.
What are the most influential trends expected to drive the enzymes market forward?
Major companies operating in the enzyme market are developing innovative products such as Lamzede to better serve patients. Lamzede (velmanase alfa) is a medication used for the treatment of alpha-mannosidosis, a rare genetic disorder caused by deficient activity of the lysosomal alpha-galactosidase-A enzyme. For instance, in May 2023, Chiesi Global Rare Diseases, a US-based pharmaceutical manufacturing company received FDA approval for Lamzede (velmanase alfa) for the treatment of non-neurological symptoms of patients with mild-to-moderate alpha-mannosidosis. Lamzede is a recombinant form of human alpha-mannosidase developed in mammalian Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is the first enzyme replacement therapy approved in the U.S. for the treatment of the non-central nervous system manifestations of alpha-mannosidosis.
What are the major regional insights for the enzymes market, and which region holds the top position?
The countries covered in the enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
What Does The Enzymes Market Report 2025 Offer?
The enzymes market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Enzyme refers to a protein that almost usually serves as a biological catalyst. It accelerates a certain chemical reaction in the cell. It is a substance that serves as a catalyst in living things, controlling the speed at which chemical processes take place without undergoing any changes.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3425
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
